Skip to main content
SpringerLink
Log in

Thrombophile Gerinnungsstörungen

  • Chapter
Transfusionsmedizin

  • 51 Accesses

Zusammenfassung

Unter dem Begriff »Thrombophilie« werden diejenigen Störungen zusammengefaßt, bei denen mit einem erhöhten Risiko für venöse Thrombosen und Embolien zu rechnen ist. Im allgemeinen wird die Bezeichnung Thrombophilie für die Thromboseneigung des venösen Schenkels des Gefäßsystems verwendet, bei bestimmten Formen der Thrombophilie können jedoch auch gehäuft Thrombosen in der arteriellen Gefäßbahn auftreten, insbesondere in den Hirnarterien und Herzkranzgefäßen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Auberger K (1992) Evaluation of a new protein-C concentrate and comparison of protein-C assays in a child with congenital protein-C deficiency. Ann Hematol 64: 146 – 151

    Article  PubMed  CAS  Google Scholar 

  2. Barbui T, Finazzi G, Viganò S, Mannucci PM (1984) L-asparaginase lowers protein C antigen. Thromb Haemostas 52:– 216

    CAS  Google Scholar 

  3. Baudo F, DeGasperi A, deCataldo F, Caimi TM, Cattaneo D, Redaelli R, Pannacciulli E, Corti A, Mazza E, Belli L (1992) Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial. Thromb Res 68: 409 – 416

    Article  PubMed  CAS  Google Scholar 

  4. Bergmann F, Hoyer PF, Vigano D’Angelo S, Mazzola G, 0estereich C, Barthels M, D’Angelo A (1995) Severe autoimmune protein S deficiency in boy with idiopathic purpura fulminans. Br J Haemat 89: 610 – 614

    Article  Google Scholar 

  5. Blauhut B, Kramar H, Vinazzer H, Bergmann H (1985) Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 39: 81 – 89

    Article  PubMed  CAS  Google Scholar 

  6. Branson HE, Katz J, Marble R, Griffin JH (1983) Inherited protein C deficiency and coumarinresponsive chronic relapsing purpura fulminans in a newborn infant. Lancet ii: 1165 – 1168

    Google Scholar 

  7. Broekmans AW, Bertina RM, Loeliger EA, Hofman V, Klinge-mann HG (1983) Protein C and the development of skin necrosis during anticoagulant therapy. Thromb Haemostas 49: 244

    Google Scholar 

  8. Broekmans AW, Veltkamp JJ, Bertina RM (1983) Congenital protein C deficiency and venous thromboembolism. A study in three Dutch families. N Engl J Med 309: 340–344

    Article  PubMed  CAS  Google Scholar 

  9. Buller HR, Ten Cate JW (1983) Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation. Thromb Haemostas 49: 128 – 131

    CAS  Google Scholar 

  10. Buller HR, Ten Cate JW (1989) Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate. Am J Med 87 [Suppl 3 B]

    Google Scholar 

  11. Conard J, Horellou MH, van Dreden P, Lecompte T, Samama M (1990) Thrombosis and pregnancy in congenital deficiencies in Antithrombin III, protein C or protein S: study of 78 women. Thromb Haemostas 63: 319–320

    CAS  Google Scholar 

  12. Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou MH, Samama MM, Rosenberg RD (1993) Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood 82: 1159 – 1164

    Google Scholar 

  13. Dahlbäck B (1995) Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 85: 607–614

    Google Scholar 

  14. D’Angelo A, Della Valle P, Crippa L, Pattarini E, Grimaldi LME, Vigano D’Angelo S (1993) Autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med 328: 1753–1757

    Google Scholar 

  15. De Stefano V, Mastrangelo S, Schwarz HP, Pola P, Flore R, Bizzi B, Leone G (1993) Replacement therapy with a purified protein C concentrate during initiation of oral anticoagulation in severe protein C congenital deficiency. Thromb Haemostas 7o: 247–249

    Google Scholar 

  16. Deutsch E, Frischauf H, Grunberger V (195o) Zwischenfälle der Dicumarolbehandlung and ihre Therapie. Z Klin Med 147: 324–333

    Google Scholar 

  17. Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planché C, De-han M, Tchernia G (1991) Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 325: 1565 –1568

    Article  PubMed  CAS  Google Scholar 

  18. Engesser L, Broekmans AW, Briet E, Brommer EJP, Bertina RM (1987) Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106: 677 – 682

    Article  PubMed  CAS  Google Scholar 

  19. Esmon CT (1992) The protein C anticoagulant pathway. Arterioscler Thromb 12: 135–145

    Article  PubMed  CAS  Google Scholar 

  20. Esmon C, Schwarz HP. An update on clinical and basic aspects of the protein C anticoagulant pathway (in press)

    Google Scholar 

  21. Estellés A, Garcia-Plaza I, Dag. A, Aznar J, Duart M, Sanz G, Pérez-Requejo JL, Espana F, Jimenez C, Abeledo G (1984) Severe inherited »homozygous« protein C deficiency in a newborn infant. Thromb Haemostas 52: 53–56

    Google Scholar 

  22. Feinstein DI (1985) Lupus anticoagulan, thrombosis, and fetal loss. N Engl J Med 313: 1348–1350

    Article  PubMed  CAS  Google Scholar 

  23. Finazzi G, Caccia R, Barbui T (1987) Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases. Thromb Haemostas 58: 10–94

    Google Scholar 

  24. Fourrier F, Lestavel P, Chopin C, Marey A, Goudemand J, Rime A, Mangaloboyi J (1990) Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. In-tens Care Med 16: 121 – 124

    Article  CAS  Google Scholar 

  25. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J (1993) Double-blind, placebo-controlled trial of anti-thrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882 – 888

    Article  PubMed  CAS  Google Scholar 

  26. Francis CW, Pellegrini VD Jr, Marder VJ, Harris CM, Totter-man S, Gabriel KR, Baughman DJ, Roemer S, Burke J, Goodman TL, Evarts CMcC (1989) Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40. J Bone Joint Surg 71: 327–335

    PubMed  CAS  Google Scholar 

  27. French J, Montgomery RR, Foster P, Endres-Brooks J, Pietryga D, Schwarz HP, Gill JC (1993) Protein C concentrate therapy in a protein C deficient patient with superior vena cava thrombosis following bone marrow transplantation. Blood 82 [Supp11]: 398 a

    Google Scholar 

  28. Gerson WT, Dickerman JD, Bovill EG, Golden E (1993) Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics 91: 418–422

    PubMed  CAS  Google Scholar 

  29. Gordon B, Haire W, Kessinger A, Duggan M, Armitage J (1991) High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 8: 497–502

    PubMed  CAS  Google Scholar 

  30. Gruber A, Blaskó G, Sas G (1986) Functional deficiency of protein C and skin necrosis in multiple myeloma. Thromb Res 42: 579–581

    Article  PubMed  CAS  Google Scholar 

  31. Harper PL, Williamson L, Park G, Smith JK, Carrell RW (1991) A pilot study of antithrombin replacement in intensive care management: the effects on mortality, coagulation and renal function. Transfus Med 1: 121 – 128

    Article  PubMed  CAS  Google Scholar 

  32. Hartman KR, Manco-Johnson M, Rawlings JS, Bower DJ, Marlar RA (1989) Homozygous protein C deficiency: early treatment with warfarin. Am J Pediatr Hematol/Oncol 11: 395–401

    CAS  Google Scholar 

  33. Hintz G, Weil J, Buchmann S, Azzam A, Auberger K, Beck C (1987) Homozygoter Säugling in einer Sippe mit erblichem Protein C-Mangel. Klin Wochenschr 65: 576 – 580

    Article  PubMed  CAS  Google Scholar 

  34. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM (1994) Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84: 1031 – 1035

    PubMed  CAS  Google Scholar 

  35. Korninger C, Klepetko W, Miholic J, Schwarz Ch, Lechner K (1987) Randomized trial of antithrombin III versus placebo in patients undergoing peritoned-venous shunt operation. Thromb Haemostas 58: 426 (Abstr)

    Google Scholar 

  36. Langley PG, Hughes RD, Forbes A, Keays R, Williams R (1993) Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepato117: 326 – 331

    Article  Google Scholar 

  37. Lechner K, Kyrle PA (1995) Antithrombin III concentrates — Are they clinically useful? Thromb Haemostas (in press)

    Google Scholar 

  38. Leclerc F, Hazelzet J, Jude B, Hofhuis W, Hue V, Martinot A, Van der Voort E (1992) Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intens Care Med 18: 202 – 205

    Article  CAS  Google Scholar 

  39. Lewandowski K, Zawilska K (1994) Protein C concentrate in the treatment of Warfarininduced skin necrosis in the protein C deficiency. Thromb Haemostas 71: 395–399

    CAS  Google Scholar 

  40. Manco-Johnson M, Nuss R (1992) Protein C concentrate prevents peripartum thrombosis. Am J Hematol 40: 69 – 70

    Article  PubMed  CAS  Google Scholar 

  41. Manco-Johnson MJ, Abshire TC, Jacobson LJ, Marlar RA (1991) Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatr 119: 793–798

    Article  PubMed  CAS  Google Scholar 

  42. Marciniak E, Wilson HD, Marlar RA (1985) Neonatal purpura fulminans: A genetic disorder related to the absence of protein C in blood. Blood 65: 15–20

    CAS  Google Scholar 

  43. Marlar RA, Endres-Brooks J, Miller C (1985) Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 66: 59–63

    PubMed  CAS  Google Scholar 

  44. Marlar RA, Montgomery RR, Broekmans AW (1989) Report on the diagnosis and treatment of homozygous protein C deficiency. Thromb Haemostas 61: 529 – 531

    CAS  Google Scholar 

  45. Mazzucconi MG, Gugliotta L, Leone G, Dragoni F, Mattioli Belmonte M, de Stefano V, Chistolini A, Tura S, Mandelli F (1994) Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A Gimema study. Blood Coagul Fibrinolys 5: 23–28

    Article  CAS  Google Scholar 

  46. Melissari E, Kakkar VV (1989) Congenital severe protein C deficiency in adults. Br J Haematol 72: 222– 228

    Article  PubMed  CAS  Google Scholar 

  47. Menache D, O’Malley JP, Schorr JB, Wagner B, Williams C, and the Cooperative Study Group (1990) Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Blood 75: 33–39

    PubMed  CAS  Google Scholar 

  48. Miletich J, Sherman L, Broze G Jr (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317: 991– 996

    Article  PubMed  CAS  Google Scholar 

  49. Mitchell CA, Rowell JA, Hau L, Young JP, Salem HH (1987) A fatal thrombotic disorder associated with an acquired inhibitor of protein C. N Engl J Med 317: 1638 –1642

    Article  PubMed  CAS  Google Scholar 

  50. Muntean W, Finding K, Gamillscheg A, Zenz W (1992) Multiple thromboses and coumarininduced skin necrosis in a young child with antiphospholipid antibodies. Thromb Haemorrh Disorders 5: 43–45

    Google Scholar 

  51. Mustafa S, Pabinger I, Mannhalter C. PS-deficiency type I: identification of point mutations in 9 of 10 families. (Submitted)

    Google Scholar 

  52. Oikawa T, Muramatsu Y, Akashi S, Usui N (1993) Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome. Nippon Jinzo Gakkai Shi 35: 1163 – 1169

    PubMed  CAS  Google Scholar 

  53. Pabinger I, Karnik R, Lechner K, Slany J, Niessner H (1986) Coumarin induced acral skin necrosis associated with hereditary protein C deficiency. Blut 52: 365– 370

    Article  PubMed  CAS  Google Scholar 

  54. Pabinger I, Brucker S, Kyrie PA, Schneider B, Korninger C, Niessner H, Lechner K (1992) Hereditary deficiency of anti-thrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for a rational patient screening. Blood Coagul Fibrinol 3: 547–553

    Article  CAS  Google Scholar 

  55. Pabinger I, Kyrie PA, Heistinger M, Eichinger S, Wittmann E, Lechner K (1994) The risk of thromboembolism in asymptomatic patients with protein C- and protein S deficiency: A prospective cohort study. Thromb Haemostas 71: 441 – 445

    CAS  Google Scholar 

  56. a. Pabinger I, Schneider B, and the GTH Study Group on Natural Inhibitors (1996) The thrombotic risk in hereditary anti-thrombin-, protein C- and protein S-deficiency: A cooperative retrospective study. Artherosclerosis, thrombosis and vascular biology (im Druck )

    Google Scholar 

  57. Palareti G, Legnani C, Maccaferri M, Gozzetti G, Mazziotti A, Martinelli G, Zanello M, Sama C, Coccheri S (1991) Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient’s disease and use of antithrombin III. Haemostasis 21: 68 – 76

    PubMed  CAS  Google Scholar 

  58. Pescatore P, Horellou HM, Conard J, Piffoux M, Van Dreden P, Ruskone-Fourmestraux A, Samama M (1993) Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis. Thromb Haemostas 69: 311 – 315

    CAS  Google Scholar 

  59. Powlars D, Larsen R, Johnson J, Hulbert T, Sun T, Patch MJ, Francis R, Chan L (1993) Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin Infect Dis 17: 254 – 261

    Article  Google Scholar 

  60. Pui CH, Chesney CM, Bergum PW, Jackson CW, Rapaport SI (1986) Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase-prednisone-vincristine therapy for leukaemia. Br J Haematol 64: 283 – 290

    Article  PubMed  CAS  Google Scholar 

  61. Rivard GE, David M, Farrell C, Gerson W, Dickerman JD, Bovill EG, Schwarz HP (1993) Treatment of purpura fulminans in meningococcemia with protein C concentrate. Thromb Haemostas 69: 23–39 (Abstr)

    Google Scholar 

  62. Rivard GE, David M, Farrell C, Schwarz HP (1995) Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr (in press)

    Google Scholar 

  63. Rosove MH, Brewer PMC (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 7o patients. Ann Intern Med 117: 303 – 308

    Article  PubMed  CAS  Google Scholar 

  64. Schipper HG, Ten Cate JW (1982) Antithrombin III transfusion in patients with hepatic cirrhosis. Br J Haematol 52:5–33

    Article  Google Scholar 

  65. Schramm W, Spannagl M, Bauer KA, Rosenberg RD, Birkner B, Linnau Y, Schwarz HP (1993) Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol 129: 753–75

    Article  Google Scholar 

  66. Schulman S, Tengborn L (1992) Treatment of venous thromboembolism in patients with congenital deficiency of anti-thrombin III. Thromb Haemostas 68: 634 – 636

    CAS  Google Scholar 

  67. Schwarz HP, Nelson K, Dreyfus M, Masterson M, Montgomery R, Rivard G, David M, Kreuz W, Parapia L, Minford A, Tillyer L, Allgrove J, Conard J, Bauer K (1993) Acute and longterm treatment of severe congenital protein C deficiency with protein C concentrate. Thromb Haemostas 69: 1698 (Abstr)

    Google Scholar 

  68. Schwartz RS, Bauer KA, Rosenberg RD, Kavanaugh EJ, Davies DC, Bogdanoff DA (1989) Clinical experience with anti-thrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. Am J Med 87 [Suppl 3 B]: 53 S-6o S

    Google Scholar 

  69. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI (1984) Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 310: 559–562

    Article  CAS  Google Scholar 

  70. Sharon C, Tirindelli MC, Mannucci PM, Tripodi A, Mariani G (1986) Homozygous protein C deficiency with moderately severe clinical symptoms. Thromb Res 41: 483– 488

    Article  PubMed  CAS  Google Scholar 

  71. Sills RH, Marlar RA, Montgomery RR, Deshpande GN, Humbert JR (1984) Severe homozygous protein C deficiency. J Pediatr 105: 409–413

    Article  PubMed  CAS  Google Scholar 

  72. Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 33o: 517–522

    Article  PubMed  CAS  Google Scholar 

  73. Tait RC, Walker ID, Perry DJ, Islam SIAM, Daly ME, McCall F, Conkie JA, Carrell RW (1994) Prevalence of antithrombin deficiency in the healthy population. BrjHaematol 87: 106–112

    Article  CAS  Google Scholar 

  74. Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol to: 369–390

    Google Scholar 

  75. Tuddenham EGD, Takase T, Thomas AE, Awidi AS, Madanat FF, Abu Hajir MM, Kernoff PBA, Hoffbrand AV (1989) Homozygous protein C deficiency with delayed onset of symptoms at 7 to to months. Thromb Res 53: 475–484

    Article  PubMed  CAS  Google Scholar 

  76. Vukovich T, Auberger K, Weil J, Engelmann H, Knöbl P, Hadorn HB (1988) Replacement therapy for a homozygous protein C deficiency-state using a concentrate of human protein C and S. BrjHaematol 70: 435–440

    Article  CAS  Google Scholar 

  77. Wada H, Deguch K, Shirakawa S, Suzuki K (1993) Successful treatment of deep vein thrombosis in homozygous protein C deficiency with activated protein C. Am J Hematol 44: 218–219

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. I. Pabinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Klinische Immunologie und Transfusionsmedizin der Universität, Langhansstr. 7, D-35385, Gießen, Deutschland

    Christian Mueller-Eckhardt

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pabinger, I. (1996). Thrombophile Gerinnungsstörungen. In: Mueller-Eckhardt, C. (eds) Transfusionsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10599-3_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10599-3_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10600-6

  • Online ISBN: 978-3-662-10599-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation